Cookie Consent
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Enzyme is pleased to announce that two of its flagship protocols — Enzyme Onyx and Enzyme Myso — will be ported to the Canton Network, making them natively available on both EVM-compatible chains and Canton. Expected to launch in early Q3, this marks a significant milestone in Enzyme's commitment to building financial infrastructure that is not only technically robust, but positioned at the forefront of the emerging institutional blockchain landscape.
Enzyme is pleased to announce a strategic partnership with CV5 Capital, a leading regulated platform for launching institutional-grade hedge funds and digital asset funds in the Cayman Islands.
Passif is a digital asset investment manager, focused on delivering stable, risk-adjusted performance independent of market direction. Their flagship product, the Passif Alpha Fund, is a tokenized hedge fund engineered to preserve capital while enabling daily liquidity and real-time investor visibility into strategy activity.
Enzyme is proud to be integrating the Chainlink Runtime Environment (CRE), a new orchestration layer designed for institutional-grade smart contract operations.
Nerite choses Onyx as their turnkey tech stack to seamlessly expand the utility of tBTC
Projects can now harness Enzyme.Blue’s all-in-one platform to launch tokenized strategies and financial products directly on Base.
Learn more about Enzyme's history and mission
